Company profile for Verseau Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. With our proprietary all-human translational system we identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease. Our data suggest that we can at least double the patient population benefitting from immunotherapy. Our i...
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. With our proprietary all-human translational system we identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease. Our data suggest that we can at least double the patient population benefitting from immunotherapy. Our initial focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
47 Wiggins Ave Bedford, MA 01730
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20220104005203/en

BUSINESSWIRE
04 Jan 2022

https://www.businesswire.com/news/home/20210907005167/en

BUSINESSWIRE
07 Sep 2021

https://www.prnewswire.com/news-releases/applied-biomath-llc-announces-collaboration-with-verseau-therapeutics-for-system-pharmacology-modeling-in-oncology-301104890.html

PRNEWSWIRE
03 Aug 2020

https://www.biospectrumasia.com/news/25/14910/psgl-1-immunotherapy-to-activate-a-anti-tumor-inflammatory-response.html

BIOSPECTRUM ASIA
18 Nov 2019

https://www.biospace.com/article/releases/3sbio-selects-verseau-s-psgl-1-targeted-antibody-vtx-0811-as-first-partnered-macrophage-checkpoint-modulator-in-immuno-oncology-collaboration/?s=89

BIOSPACE
18 Nov 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty